AAAAAA
Results:
1-11
|
Results: 11
Authors:
Lambeng, N
Michel, PP
Agid, Y
Ruberg, M
Citation: N. Lambeng et al., The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor, NEUROSCI L, 297(2), 2001, pp. 133-136
Authors:
Troadec, JD
Marien, M
Darios, F
Hartmann, A
Ruberg, M
Colpaert, F
Michel, PP
Citation: Jd. Troadec et al., Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress, J NEUROCHEM, 79(1), 2001, pp. 200-210
Authors:
Douhou, A
Troadec, JD
Ruberg, M
Raisman-Vozari, R
Michel, PP
Citation: A. Douhou et al., Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptors, J NEUROCHEM, 78(1), 2001, pp. 163-174
Authors:
Hartmann, A
Michel, PP
Troadec, JD
Mouatt-Prigent, A
Faucheux, BA
Ruberg, M
Agid, Y
Hirsch, EC
Citation: A. Hartmann et al., Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neuronsin Parkinson's disease?, J NEUROCHEM, 76(6), 2001, pp. 1785-1793
Authors:
Hartmann, A
Hunot, S
Michel, PP
Muriel, MP
Vyas, S
Faucheux, BA
Mouatt-Prigent, A
Turmel, H
Srinivasan, A
Ruberg, M
Evan, GI
Agid, Y
Hirsch, EC
Citation: A. Hartmann et al., Caspase-3: A vulnerability factor and final effector in apoptotic death ofdopaminergic neurons in Parkinson's disease, P NAS US, 97(6), 2000, pp. 2875-2880
Authors:
Muriel, MP
Lambeng, N
Darios, F
Michel, PP
Hirsch, EC
Agid, Y
Ruberg, M
Citation: Mp. Muriel et al., Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death, J COMP NEUR, 426(2), 2000, pp. 297-315
Authors:
Murer, MG
Raisman-Vozari, R
Yan, Q
Ruberg, M
Agid, Y
Michel, PP
Citation: Mg. Murer et al., Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons, NEUROREPORT, 10(4), 1999, pp. 801-805
Authors:
Agid, Y
Ahlskog, E
Albanese, A
Calne, D
Chase, T
De Yebenes, J
Factor, S
Fahn, S
Gershanik, O
Goetz, C
Koller, W
Kurth, M
Lang, A
Lees, A
Lewitt, P
Marsden, D
Melamed, E
Michel, PP
Mizuno, Y
Obeso, J
Oertel, W
Olanow, W
Poewe, W
Pollak, P
Przedzorski, S
Quinn, N
Raisman-Vozari, R
Rajput, A
Stocchi, F
Tolosa, E
Citation: Y. Agid et al., Levodopa in the treatment of Parkinson's disease: A consensus meeting, MOVEMENT D, 14(6), 1999, pp. 911-913
Authors:
Michel, PP
Lambeng, N
Ruberg, M
Citation: Pp. Michel et al., Neuropharmacologic aspects of apoptosis: Significance for neurodegenerative diseases, CLIN NEUROP, 22(3), 1999, pp. 137-150
Authors:
Michel, PP
Marien, M
Ruberg, M
Colpaert, F
Agid, Y
Citation: Pp. Michel et al., Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes, J NEUROCHEM, 72(5), 1999, pp. 2074-2082
Authors:
Lambeng, N
Michel, PP
Brugg, B
Agid, Y
Ruberg, M
Citation: N. Lambeng et al., Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP, BRAIN RES, 821(1), 1999, pp. 60-68
Risultati:
1-11
|